Genomic health, inc (GHDX)
CashFlow / Quarterly
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Operating activities
Net income

18,694

15,987

12,999

8,910

12,225

8,317

-3,775

1,879

-2,191

-2,739

-806

1,352

-2,820

-6,100

-6,351

-2,735

-11,843

-9,237

-9,493

-6,267

-6,262

-4,618

-7,445

-9,369

489

-2,994

-883

1,959

3,713

1,800

777

2,559

3,225

2,348

-286

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

3,359

3,103

3,412

3,321

3,124

3,069

3,155

3,186

3,139

3,027

2,407

2,279

2,289

2,186

2,179

1,993

1,674

1,674

1,728

1,673

1,707

1,733

1,757

1,554

1,622

1,603

1,545

1,497

1,209

1,230

1,535

1,804

1,799

1,814

1,893

Employee stock-based compensation

6,483

6,506

6,281

5,348

5,401

5,155

5,186

4,999

4,955

5,197

5,105

4,201

4,713

4,847

4,542

3,950

3,928

3,951

4,176

3,942

3,986

4,254

4,356

4,612

4,357

4,129

4,359

4,297

3,402

3,711

3,694

2,930

2,907

2,980

2,918

Write-off of previously capitalized software costs

-

-

-

47

-47

-21

2,368

-

-

-

-

-

-

-

-

0

58

490

87

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of long-lived assets

-

-

-

258

5

-59

2,154

-

-

-

-

0

0

0

56

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of assets held for sale

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

149

0

265

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal of property and equipment

-8

-30

-709

-

-

-

-

0

0

0

-35

-

-

-

-

19

42

0

19

-21

48

57

-33

-

4

-3

4

-

-

-

-

-

-

-

-

Outside director restricted stock awarded in lieu of fees

75

50

50

50

50

50

50

50

50

50

50

50

50

50

50

50

50

50

50

60

60

60

50

60

60

60

50

52

40

40

40

-

-

-

-

Gain on sale of corporate debt securities

0

0

13

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of equity securities

-

-

-

-

-

-

-

0

0

0

2,807

1,199

0

676

1,333

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Discount on convertible promissory note

-

-

-

-

-

-

-62

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized net gain on revaluation of equity investments

-

-301

449

-

-

1,283

127

-

-

-

-

-

2,346

-5,191

3,787

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax benefit from unrealized gain on available-for-sale marketable securities, net

-

-

-

-

-

-

-

0

0

0

820

-

-

1,455

-1,107

-

-

-

5,600

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax benefit from unrealized gain on available-for-sale marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6,205

1,344

5,626

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Share of loss of equity method investee

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-53

-45

-46

-47

-42

-30

Changes in assets and liabilities:
Accounts receivable

1,568

-4,941

7,717

-22

2,571

2,415

1,283

-4,423

3,157

-2,166

-586

1,497

71

-5,218

1,665

3,410

854

-2,079

63

3,949

-804

2,870

-545

3,852

-1,096

-355

4,792

2,327

-1,773

862

-240

-1,569

3,277

3,107

1,956

Prepaid expenses and other assets

-2,147

-2,435

3,136

3,632

-1,244

-710

786

2,085

-752

-675

-722

3,100

270

706

480

909

531

-2,400

2,252

-499

494

-1,051

315

825

608

-756

771

330

368

525

376

601

78

-316

270

Accounts payable

-654

-1,243

-563

2,455

1,170

158

4,591

-8,033

3,564

-57

2,218

-2,609

398

73

-2,441

2,765

-1,086

-969

239

313

380

-2,075

2,367

2,634

-208

-290

-898

1,489

-97

263

-3,799

4,303

827

-2,842

769

Accrued compensation and employee benefits

5,843

4,052

-12,418

5,325

7,382

-163

-3,040

334

3,264

2,246

-8,791

3,225

4,161

456

-2,181

1,435

2,806

1,610

-1,320

3,174

-787

2,814

-1,377

1,906

-813

2,625

-1,832

1,889

-245

1,602

-1,295

1,141

189

1,160

-268

Accrued expenses and other liabilities

-3,461

2,220

-2,703

1,847

1,825

1,052

-2,151

3,274

-905

564

1,231

-783

-1,542

531

3,439

-4,826

944

-4,364

5,283

109

1,094

1,417

468

-1,680

1,235

-307

2,049

-1,438

2,088

-866

1,824

-1,838

1,842

99

-1,353

Deferred revenues

0

0

-121

-

-

-

-

-

-

-

-

-28

-206

-140

-57

180

-273

256

-67

146

-84

265

-578

-548

856

225

-321

-868

-148

-302

-368

-170

-390

-288

-355

Net cash provided by operating activities

32,165

38,382

-3,669

24,576

29,745

15,961

6,280

9,134

9,569

11,129

770

2,809

8,796

7,194

-5,349

-2,186

1,036

-3,404

-7,277

-318

505

1,974

126

-4,197

8,082

6,165

-1,498

6,137

11,364

6,144

2,317

11,873

7,084

2,522

1,122

Investing activities
Purchases of property and equipment

5,736

7,281

2,978

3,123

2,728

1,989

2,236

2,873

2,346

2,913

5,144

10,998

1,909

1,568

5,311

7,427

6,548

5,139

4,369

4,867

1,909

2,510

1,169

3,549

3,044

2,198

2,217

3,886

2,677

1,151

2,342

1,642

1,700

664

2,177

Proceeds from sale of property and equipment

-

-

-

-

-

-

-

0

0

0

10

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of marketable securities

100,330

84,585

39,991

56,034

52,141

40,345

24,043

21,097

37,814

29,739

20,599

13,218

20,572

23,725

12,207

22,138

11,257

12,074

31,274

24,579

13,520

35,375

23,326

35,269

24,289

29,336

18,289

42,074

23,108

15,357

23,031

44,511

21,917

22,038

45,527

Maturities of marketable securities

48,022

36,315

64,887

17,054

37,403

29,503

20,019

12,400

29,470

16,682

13,250

15,500

11,250

20,250

19,757

31,934

20,265

17,060

37,180

18,084

19,272

36,054

21,500

37,457

24,449

33,876

20,387

30,035

10,965

24,600

24,560

26,031

29,900

23,328

32,744

Proceeds from sales of corporate debt securities

0

0

23,305

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sales of marketable securities

-

-

-

-

-

-

-

0

0

0

10,155

4,600

0

1,538

3,579

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

2,300

Net cash used in investing activities

-58,044

-55,551

45,223

-42,048

-17,466

-15,331

-6,260

-13,570

-10,690

-15,970

-2,328

-4,116

-17,323

-3,505

5,818

2,397

2,502

-153

1,537

-11,357

1,843

-1,714

-2,995

-6,361

-2,872

2,346

-119

-19,273

-15,829

7,692

-813

-20,122

6,283

626

-17,260

Financing activities
Proceeds from issuance of common stock under stock plans

7,321

6,934

9,873

10,261

3,441

11,396

1,152

7,091

2,163

6,453

6,069

7,905

2,033

6,440

632

4,431

872

4,515

2,379

4,327

2,568

4,139

996

4,177

1,902

7,351

3,158

4,549

5,410

6,187

2,618

2,837

1,164

2,445

3,112

Withholding taxes related to restricted stock units net share settlement

347

204

11,618

389

318

190

4,601

157

226

178

4,136

199

167

174

2,929

119

151

145

3,427

164

172

146

3,165

121

153

137

2,434

-

-

-

-

-

-

-

-

Payments on finance lease liabilities

52

52

51

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repurchase of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

15

-

-

-

-

-

-

-

-

Net cash provided by financing activities

6,922

6,678

-1,796

9,872

3,123

11,206

-3,449

6,934

1,937

6,275

1,933

7,706

1,866

6,266

-2,297

4,312

721

4,370

-1,048

4,163

2,396

3,993

-2,169

4,056

1,749

7,214

709

-26,818

5,410

6,187

2,618

2,837

1,164

2,445

3,112

Net increase in cash, cash equivalents and restricted cash

-18,957

-10,491

39,758

-7,600

15,402

11,836

-3,429

2,498

816

1,434

375

6,399

-6,661

9,955

-1,828

4,523

4,259

813

-6,788

-7,512

4,744

4,253

-5,038

-6,502

6,959

15,725

-908

-39,954

945

20,023

4,122

-5,412

14,531

5,593

-13,026

Cash paid for income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

108

-

-

-

36

170

0

13

60

Non-cash investing and financing activities
Accrued purchases of property and equipment

824

-1,163

2,411

210

153

214

533

-664

-624

-481

2,486

-2,350

3,197

314

291

-281

1,258

369

2,501

935

610

-1,486

1,750

7

276

-517

1,372

-

-

-

-

-

-

-

-

Change in fair value of investments

-1,239

-301

449

-663

128

-119

200

-

-

-

-

-

-

-

-

2,186

-16,912

-4,150

23,145

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-